{
  "actions": [
    {
      "acted_at": "2025-04-10",
      "action_code": "10000",
      "references": [],
      "text": "Introduced in Senate",
      "type": "action"
    },
    {
      "acted_at": "2025-04-10",
      "action_code": "",
      "committees": [
        "SSHR"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Read twice and referred to the Committee on Health, Education, Labor, and Pensions.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "s1414-119",
  "bill_type": "s",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "Referred To"
      ],
      "committee": "Senate Health, Education, Labor, and Pensions",
      "committee_id": "SSHR"
    }
  ],
  "congress": "119",
  "cosponsors": [],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2025-04-10",
  "number": "1414",
  "official_title": "A bill to amend the Public Health Service Act to provide that clinical studies required for licensure of biological products as biosimilar shall not be required to include the assessment of immunogenicity, pharmacodynamics, or comparative clinical efficacy.",
  "popular_title": null,
  "related_bills": [],
  "short_title": "Expedited Access to Biosimilars Act",
  "sponsor": {
    "bioguide_id": "P000603",
    "district": null,
    "name": "Paul, Rand",
    "state": "KY",
    "title": "Sen.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2025-04-10",
  "subjects": [
    "Health"
  ],
  "subjects_top_term": "Health",
  "summary": null,
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Expedited Access to Biosimilars Act",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Expedited Access to Biosimilars Act",
      "type": "short"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "A bill to amend the Public Health Service Act to provide that clinical studies required for licensure of biological products as biosimilar shall not be required to include the assessment of immunogenicity, pharmacodynamics, or comparative clinical efficacy.",
      "type": "official"
    }
  ],
  "updated_at": "2025-05-20T13:31:07Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/119/s/BILLSTATUS-119s1414.xml"
}